A Stimuli-Responsive Hybrid Platform for the On-Demand Delivery of Vitamin B12
Source abstract
Abstract
Physically triggered drug release is an emerging field focused on developing materials capable of modulating release kinetics in response to external stimuli. In this work, we present a strategy for the fabrication and evaluation of heat-mediated drug release from electrospun fibers composed of a polyacrylonitrile (PAN) and poly (methyl vinyl ether-alt-maleic acid) (PMA-MVE) blend, encapsulating vitamin B12 (B12-NFs) as a model. Following thermal treatments at 90, 120, and 180 °C, results from SEM, TGA, DSC, and FTIR confirmed that increasing the crosslinking temperature promoted the formation of a more hydrophobic matrix (contact angle > 150°), which effectively reduced spontaneous drug leakage. As a proof-of-concept, we evaluated the sensitivity of the elaborated B12 to heating in aqueous media using UV-Vis spectrometry. The results indicate that the release kinetics followed a sigmoidal profile governed by the dissolution Gompertz model. This laboratory-scale evaluation establishes the fundamental mechanisms for magnetically triggered platforms based on polymeric blends, providing a robust framework for the design of remotely activated, non-invasive drug delivery platforms.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Folate and B Vitamins Research · Porphyrin Metabolism and Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC, Universidad de Zaragoza, 50009 Zaragoza, Spain
References (62)
Show source-provided references
1. Placha, D., and Jampilek, J. (2021). Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics, 13.10.3390/pharmaceutics13010064 ↗
2. Liu, J., Ting, J.P., Al-Azzam, S., Ding, Y., and Afshar, S. (2021). Therapeutic advances in diabetes, autoimmune, and neurological diseases. Int. J. Mol. Sci., 22.10.3390/ijms22062805 ↗
3. Complement, a target for therapy in inflammatory and degenerative diseases10.1038/nrd4657 ↗
4. Helminth-derived biomacromolecules as therapeutic agents for treating inflammatory and infectious diseases: What lessons do we get from recent findings?10.1016/j.ijbiomac.2023.124649 ↗
5. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity10.1002/wnan.1758 ↗
6. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects10.1016/j.medidd.2022.100134 ↗
7. Cheng, X., Xie, Q., and Sun, Y. (2023). Advances in nanomaterial-based targeted drug delivery systems. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1177151 ↗
8. Review on metal nanoparticles as nanocarriers: Current challenges and perspectives in drug delivery systems10.1007/s42247-021-00335-x ↗
9. Unlocking the potential and versatility of quantum dots: From biomedical to environmental applications and smart micro/nanorobots10.1002/admi.202300970 ↗
10. Organic and inorganic nanomaterials: Fabrication, properties and applications10.1039/D3RA01421E ↗
11. Tailored mesoporous inorganic biomaterials: Assembly, functionalization, and drug delivery engineering10.1002/adma.202005215 ↗
12. Inorganic nanomaterials with rapid clearance for biomedical applications10.1039/D0CS00461H ↗
13. Recent advances in biopolymer based electrospun nanomaterials for drug delivery systems10.1002/pat.6309 ↗
14. Recent advances in nanomaterial-based drug delivery systems10.1016/j.nanoso.2024.101103 ↗
15. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science10.1016/j.jddst.2021.102487 ↗
16. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment10.1016/j.mtbio.2022.100223 ↗
17. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy10.1080/10717544.2021.2021324 ↗
18. Application of nanomaterials in development of electrochemical sensors and drug delivery systems for anticancer drugs and cancer biomarkers10.1080/10408347.2020.1808442 ↗
19. Nano-drug delivery systems based on natural products10.2147/IJN.S443692 ↗
20. A review on electrospun nanofibers for multiple biomedical applications10.1002/pat.5896 ↗
21. Gelatin nanofibers: Recent insights in synthesis, bio-medical applications and limitations10.1016/j.heliyon.2023.e16228 ↗
22. Nanofibers for the immunoregulation in biomedical applications10.1007/s42765-022-00191-2 ↗
23. Electrospun nanofibrous membrane for biomedical application10.1007/s42452-022-05056-2 ↗
24. Nirwan, V.P., Kowalczyk, T., Bar, J., Buzgo, M., Filová, E., and Fahmi, A. (2022). Advances in electrospun hybrid nanofibers for biomedical applications. Nanomaterials, 12.10.3390/nano12111829 ↗
25. A systematic review on green and natural polymeric nanofibers for biomedical applications10.1016/j.ijbiomac.2024.130135 ↗
26. Molecular targeted therapy for anticancer treatment10.1038/s12276-022-00864-3 ↗
27. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives10.1038/s41392-021-00572-w ↗
28. Janczura, M., Sip, S., and Cielecka-Piontek, J. (2022). The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients. Pharmaceutics, 14.10.3390/pharmaceutics14040834 ↗
29. Architectural design of block copolymers10.1021/acs.macromol.3c01730 ↗
30. Biomimetic electrospun nanofibers for tissue regeneration10.1088/1748-6041/1/3/R01 ↗
31. Electrospinning of polymer nanofibers for tissue regeneration10.1016/j.progpolymsci.2014.12.001 ↗
32. Tailoring micro/nano-fibers for biomedical applications
33. Preparation of fibers with nanoscaled morphologies: Electrospinning of polymer blends10.1002/pen.10799 ↗
34. Nagam Hanumantharao, S., and Rao, S. (2019). Multi-functional electrospun nanofibers from polymer blends for scaffold tissue engineering. Fibers, 7.10.3390/fib7070066 ↗
35. Electrospinning for drug delivery applications: A review10.1016/j.jconrel.2021.03.033 ↗
36. Electrospinning: A promising technique for drug delivery systems10.1515/rams-2020-0041 ↗
37. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery10.1016/j.addr.2009.07.007 ↗
38. Polymeric nanofibers for drug delivery applications: A recent review10.1007/s10856-022-06700-4 ↗
39. Photoactivatable nanogenerators of reactive species for cancer therapy
40. Mechanisms for tuning engineered nanomaterials to enhance radiation therapy of cancer10.1002/advs.202003584 ↗
41. Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy10.1016/j.actbio.2021.05.023 ↗
42. Recent progress in nanostructured smart drug delivery systems for cancer therapy: A review10.1021/acsabm.2c00002 ↗
43. Substituted Poly (Methyl Vinyl Ether-alt-Maleic Anhydride) for the Release Control and Targeting of Methotrexate10.1002/(SICI)1521-4184(199811)331:11<347::AID-ARDP347>3.0.CO;2-N ↗
44. Poly (methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization10.1002/marc.201300868 ↗
45. Development of Poly (Methyl vinyl ether-alt-maleic acid) Microneedles for Transdermal Delivery of Atorvastatin Calcium10.2174/1389201021666200217103302 ↗
46. Optimization of Poly (methyl vinyl ether-co-maleic acid) Electrospun Nanofibers as a Fast-Dissolving Drug Delivery System10.4103/abr.abr_83_17 ↗
47. Poly (methyl vinyl ether-alt-maleic acid) and ethyl monoester as building polymers for drug-loadable electrospun nanofibers10.1038/s41598-017-17542-4 ↗
48. Characterisation of Blends Based on Hydroxyethylcellulose and Maleic Acid-alt-Methyl Vinyl Ether10.1002/macp.200500069 ↗
49. Dynamic Bond Chemistry in Soft Materials: Bridging Adaptability and Mechanical Robustness10.1021/acs.chemrev.5c00566 ↗
50. A pH/Temperature-Sensitive s-IPN Based on Poly (vinyl alcohol), Poly (vinyl methyl ether-alt-maleic acid) and Poly (vinyl methyl ether) Prepared by Autoclaving10.1007/s13233-022-0044-6 ↗
51. Antimicrobial hydrogels based on autoclaved poly (vinyl alcohol) and poly (methyl vinyl ether-alt-maleic anhydride) mixtures for wound care applications10.1039/C6RA08234C ↗
52. Dual-Polymeric Resin Based on Poly (methyl vinyl ether-alt-maleic anhydride) and PAMAM Dendrimer as a Versatile Supramolecular Adsorbent10.1021/acsapm.0c01254 ↗
53. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles10.1016/S0378-5173(02)00182-5 ↗
54. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties10.1016/S0168-3659(03)00066-X ↗
55. Bioadhesive poly (methyl vinyl ether-co-maleic anhydride)-TPGS copolymer modified PLGA/lipid hybrid nanoparticles for improving intestinal absorption of cabazitaxel10.1016/j.ijpharm.2021.121301 ↗
56. Magnetic nanofibers for remotely triggered catalytic activity applied to the degradation of organic pollutants10.1016/j.matdes.2023.111615 ↗
57. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
58. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets10.1021/js960473x ↗
59. Investigation of the chemical changes during thermal treatment of polyacrylonitrile and 15N-labelled polyacrylonitrile by means of in-situ FTIR and 15N NMR spectroscopy10.1016/j.polymdegradstab.2017.10.018 ↗
60. Separator membrane from crosslinked poly (vinyl alcohol) and poly (methyl vinyl ether-alt-maleic anhydride)10.3390/nano5020398 ↗
61. Pore size and flux behavior of polyvinylidene fluoride and polymethyl vinyl ether-alt-maleic anhydride with TiO210.1016/j.cej.2013.09.037 ↗
62. Chemical reactions and reactivity of primary, secondary, and tertiary diamines with acid functionalized polymers10.1002/pola.1992.080300811 ↗